Baxter Healthcare Corporation has recalled 44,208 containers of its Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL. This recall was issued because the product was found to have microbial contamination, specifically endotoxin testing results that were outside of acceptable limits. This sterile injection is typically provided in a 1,000 mL single-dose container for medical use.
Injecting a product contaminated with endotoxins can cause severe medical complications, including high fever, chills, shaking, and systemic inflammation that can lead to life-threatening sepsis.
Recall #: D-0649-2024
Label, Heparin Sodium in 0.9% Sodium Chloride Injection
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.